Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Douglas A. McIntyre | Sep 24, 2008 at 5:52 PM EDT

Biotech Bonanza: Ligand Takes out Pharmacopeia (LGND, PCOP)

This might not be the biggest of biotech mergers out there, but deals are continuing in the bio-space. Ligand Pharmaceuticals…

Douglas A. McIntyre | Sep 23, 2008 at 11:07 AM EDT

Higher ImClone Bid Challenges Icahn At His Own Game (IMCL, BMY)

ImClone Systems Inc. (NASDAQ: IMCL) is among the biotech bonanza merger candidates with one deal on the table and perhaps…

Douglas A. McIntyre | Sep 17, 2008 at 8:03 AM EDT

Day Trader Alert: Gilead Sciences (GILD)

Gilead Sciences Inc. (NASDAQ: GILD) is trading down this morning. Goldman Sachs maintained its buy rating on the stock, but…

Douglas A. McIntyre | Sep 17, 2008 at 5:47 AM EDT

Abbott (ABT): A Resurrection Of The Stent Business

The stent business in the US has been dying and it is in trouble overseas. Stents are small mesh tubs…

Douglas A. McIntyre | Sep 15, 2008 at 9:26 AM EDT

Medarex & Bristol-Myers Show Positive Metastatic Melanoma Data (BMY, MEDX)

There is some very hopeful data out there this morning on cancer survival. Bristol-Myers Squibb Co. (NYSE: BMY) and Medarex,…

Douglas A. McIntyre | Sep 11, 2008 at 10:03 AM EDT

Bristol-Myers Re-Offers No New Offer for ImClone (IMCL, BMY)

Bristol-Myers Squibb (NYSE: BMY) has sent a letter to Imclone Systems (NASDAQ: IMCL) in response to yesterday’s rejection of its…

Douglas A. McIntyre | Sep 10, 2008 at 8:21 AM EDT

Day Trader Alert: ImClone Systems (IMCL, BMY)

ImClone Systems Inc. (NASDAQ: IMCL) is a biotech buyout bonanza stock that traders and investors have been watching closely. The…

Douglas A. McIntyre | Sep 9, 2008 at 9:35 AM EDT

Cardica Adding U.S. to E.U. & Japan Sales (CRDC)

A usually quiet Cardica, Inc. (NASDAQ: CRDC) is seeing a huge move in its stock today on strong upside volume. …

Douglas A. McIntyre | Sep 8, 2008 at 3:55 PM EDT

Biodel Trades Down Close To Net Asset Value (BIOD)

If you just read headlines on Biodel Inc. (Nasdaq: BIOD) this morning, you would have thought the news coming out…

Douglas A. McIntyre | Sep 2, 2008 at 8:11 AM EDT

More Blight For Merck (MRK)

Merck (MRK) and Schering-Plough (SGP) make two of the most widely sold drugs in the world. One is cholesterol drug…

Douglas A. McIntyre | Sep 1, 2008 at 11:26 AM EDT

Another Stent Failure For Boston Scientific (BSX)

Investors have another reason to bail out of Boston Scientific (BSX). It has been in a battle with the medical…

Douglas A. McIntyre | Aug 27, 2008 at 4:22 AM EDT

Eli Lilly’s (LLY) Gift To The Funeral Industry

The National Funeral Directors Association must be sending “thank you” cards to Eli Lilly (LLY) and it partner Amylin (AMLN).…

Douglas A. McIntyre | Aug 25, 2008 at 7:45 AM EDT

Biodel & Backers Tapping Cash Via Equity Sale (BIOD)

Biodel Inc. (NASDAQ: BIOD) has filed with the SEC to sell up to 8.5 million shares of common stock. The…

Douglas A. McIntyre | Aug 22, 2008 at 1:31 PM EDT

Alpharma Already Wants More From King (ALO, KG)

Alpharma, Inc. (NYSE: ALO) has already responded to King Pharmaceuticals Inc. (NYSE: KG) regarding the $33.00 per share offer made…

Douglas A. McIntyre | Aug 18, 2008 at 2:29 PM EDT

Eil Lilly (LLY) Death Drug Needs More Regulation

If there wasn’t enough already wrong with the FDA drug approval process, diabetes drug Byetta, created for patients by Elli…

1 … 347 348 349 350 351 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Biotech Bonanza: Ligand Takes out Pharmacopeia (LGND, PCOP)

Higher ImClone Bid Challenges Icahn At His Own Game (IMCL, BMY)

Day Trader Alert: Gilead Sciences (GILD)

Abbott (ABT): A Resurrection Of The Stent Business

Medarex & Bristol-Myers Show Positive Metastatic Melanoma Data (BMY, MEDX)

Bristol-Myers Re-Offers No New Offer for ImClone (IMCL, BMY)

Day Trader Alert: ImClone Systems (IMCL, BMY)

Cardica Adding U.S. to E.U. & Japan Sales (CRDC)

Biodel Trades Down Close To Net Asset Value (BIOD)

More Blight For Merck (MRK)

Another Stent Failure For Boston Scientific (BSX)

Eli Lilly’s (LLY) Gift To The Funeral Industry

Biodel & Backers Tapping Cash Via Equity Sale (BIOD)

Alpharma Already Wants More From King (ALO, KG)

Eil Lilly (LLY) Death Drug Needs More Regulation

At 59, Tapping a $1.5 Million 401(k) First Could Trigger $55,000 in Penalties and Taxes

Suze Orman to 50-Year-Old With $33K Divorce Debt Eyeing 401(k) Withdrawal: ‘Don’t Do It.’

Donald Trump’s Truth Social Stake Hit $4 Billion. Everyday Investors Who Chased the ‘DJT’ Meme Stock Have Watched Billions Evaporate

At 59, Tapping a $1.5 Million 401(k) First Could Trigger $55,000 in Penalties and Taxes

Suze Orman to 50-Year-Old With $33K Divorce Debt Eyeing 401(k) Withdrawal: 'Don't Do It.'

At 59, Tapping a $1.5 Million 401(k) First Could Trigger $55,000 in Penalties and Taxes

Suze Orman to 50-Year-Old With $33K Divorce Debt Eyeing 401(k) Withdrawal: ‘Don’t Do It.’

Health and Healthcare Articles

All Health and Healthcare Articles

Biotech Bonanza: Ligand Takes out Pharmacopeia (LGND, PCOP)

Higher ImClone Bid Challenges Icahn At His Own Game (IMCL, BMY)

Day Trader Alert: Gilead Sciences (GILD)

Abbott (ABT): A Resurrection Of The Stent Business

Medarex & Bristol-Myers Show Positive Metastatic Melanoma Data (BMY, MEDX)

Bristol-Myers Re-Offers No New Offer for ImClone (IMCL, BMY)

Day Trader Alert: ImClone Systems (IMCL, BMY)

Cardica Adding U.S. to E.U. & Japan Sales (CRDC)

Biodel Trades Down Close To Net Asset Value (BIOD)

More Blight For Merck (MRK)

Another Stent Failure For Boston Scientific (BSX)

Eli Lilly’s (LLY) Gift To The Funeral Industry

Biodel & Backers Tapping Cash Via Equity Sale (BIOD)

Alpharma Already Wants More From King (ALO, KG)

Eil Lilly (LLY) Death Drug Needs More Regulation

At 59, Tapping a $1.5 Million 401(k) First Could Trigger $55,000 in Penalties and Taxes

Suze Orman to 50-Year-Old With $33K Divorce Debt Eyeing 401(k) Withdrawal: ‘Don’t Do It.’

Donald Trump’s Truth Social Stake Hit $4 Billion. Everyday Investors Who Chased the ‘DJT’ Meme Stock Have Watched Billions Evaporate

Featured Reads

At 59, Tapping a $1.5 Million 401(k) First Could Trigger $55,000 in Penalties and Taxes

Suze Orman to 50-Year-Old With $33K Divorce Debt Eyeing 401(k) Withdrawal: 'Don't Do It.'